Pay in 4 interest-free payments of $5.69 Learn more
Ships within 48 hours · Estimated delivery Sep 30 - Oct 5
In one phase 2 study: Pancreatitis was reported in about 0.4% of participants (1 out of 267) Gallbladder issues affected roughly 1.1%, with no cases in the placebo group Heart rhythm changes were reported more often in people taking retatrutide (about 6% compared to 3% with placebo) Liver enzyme increases were rare (around 1%), and overall liver health markers stayed stable over time
Clarity: If you receive a new shipment of your medication, recognizing its color and packaging can quickly reassure you that you have the correct product
This innovative medication stands out due to its unique dual-agonist mechanism, targeting two key incretin hormones in the body: Glucose-dependent Insulinotropic Polypeptide (GIP) and Glucagon-like Peptide-1 (GLP-1)
Our perimenopause peptide guide and peptides for women over 40 address the specific challenges that hormonal transitions add to weight management protocols
US$ 28.88
US$ 23.11
US$ 26.71
